Pulmocef CV 250mg/62.50mg Tablet
By Pulmocef-CV
Rx
10 Tablet in a Strip

Composition
Cefuroxime(250mg) + Clavulanic Acid(62.50mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
September, 2025
About Pulmocef CV 250mg/62.50mg Tablet
Pulmocef CV 250mg/62.50mg Tablet is a combination medication specifically designed to combat various bacterial infections. By targeting and inhibiting the growth of harmful microorganisms, this medicine serves to halt the spread of infections within the body. It is essential to note that Pulmocef CV 250mg/62.50mg Tablet is classified as a prescription drug, emphasizing the importance of adhering to the prescribed dosage regimen for optimal results.
To maximize the efficacy of Pulmocef CV 250mg/62.50mg Tablet, it is recommended to take the medication consistently at the same time each day. Although it is acceptable to consume this medication with or without food, exceeding the prescribed dosage can potentially lead to adverse effects on overall health. In cases of missed doses, it is advisable to promptly take the missed dose unless the next scheduled dose is imminent. Completing the full course of treatment is crucial, even if symptoms improve, to prevent the risk of resurgence due to premature discontinuation.
While Pulmocef CV 250mg/62.50mg Tablet effectively treats bacterial infections, users may experience common side effects such as nausea, vomiting, diarrhea, and indigestion. If these side effects become severe or persistent, consulting a healthcare provider is recommended. Additionally, any signs of allergic reactions, including rashes, swelling, or breathing difficulties, necessitate urgent medical attention.
Individuals considering Pulmocef CV 250mg/62.50mg Tablet should disclose their current medication regimen and existing health conditions to their healthcare provider. Pregnant or breastfeeding individuals must seek medical advice before initiating treatment. It is advisable to avoid alcohol consumption, as it may intensify drowsiness when used concurrently with the medication. While Pulmocef CV 250mg/62.50mg Tablet typically does not impact driving abilities, caution should be exercised if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are essential for facilitating a speedy recovery. Periodic laboratory and diagnostic tests may be required to monitor the medication's effects on the body's response.
Benefits
Pulmocef CV 250mg/62.50mg Tablet offers several benefits in the treatment of bacterial infections. The tablet contains two powerful medicines, Cefuroxime and Clavulanic Acid, which work in tandem to effectively combat bacterial infections. Cefuroxime functions by halting the growth of bacteria, while Clavulanic Acid plays a crucial role in reducing resistance and amplifying the efficacy of Cefuroxime against bacteria.
This combination of medicines is particularly effective in treating a wide range of bacterial infections, including those affecting the ears, sinuses, throat, lungs, urinary tract, skin, and soft tissues. Patients typically experience an improvement in their symptoms within a few days of starting treatment with Pulmocef CV, but it is essential to complete the prescribed course even if feeling better. This is crucial to ensure that all bacteria are eradicated and do not develop resistance, thereby preventing recurrent or persistent infections.
Overall, Pulmocef CV 250mg/62.50mg Tablet provides a comprehensive approach to tackling bacterial infections by targeting the root cause and promoting complete recovery. It offers relief from symptoms, accelerates the healing process, and helps prevent the development of antibiotic resistance, safeguarding against future infections.
How to use the Pulmocef CV 250mg/62.50mg Tablet
To use Pulmocef CV 250mg/62.50mg Tablet, follow your doctor’s instructions on dosage and duration. Swallow the tablet whole, without chewing, crushing, or breaking it. You can take the tablet with or without food, but it is recommended to take it at the same time each day for best results. Make sure to adhere to the prescribed dose and schedule to maximize the effectiveness of the medication. If you have any questions or concerns about how to use this tablet, consult your doctor or pharmacist for clarification.
Uses of Pulmocef CV 250mg/62.50mg Tablet
Pulmocef CV 250mg/62.50mg Tablet is primarily used for the treatment of bacterial infections. It is effective in fighting against a variety of bacterial strains, helping to alleviate infections in the body. The medication works by targeting and destroying the harmful bacteria, allowing the body to recover and heal. Pulmocef CV 250mg/62.50mg Tablet is commonly prescribed by healthcare professionals to combat bacterial infections and promote recovery. It is important to follow the prescribed dosage and complete the full course of treatment to ensure the best results in treating bacterial infections.
What conditions Pulmocef CV 250mg/62.50mg Tablet treats?
Pulmocef CV 250mg/62.50mg Tablet is used in the treatment of various bacterial infections. It contains two medicines, Cefuroxime and Clavulanic Acid, that work together to eliminate the bacteria causing the infections. This combination is effective against infections in the ear, sinus, throat, lung, urinary tract, skin, and soft tissues. It is important to complete the prescribed course of treatment to ensure all bacteria are eradicated and to prevent resistance development. Common side effects may include nausea, vomiting, and diarrhea, and immediate medical attention is necessary for any allergic reactions.
Should you consult a doctor?
If you experience aggravated side effects such as nausea, vomiting, diarrhea, or indigestion while taking Pulmocef CV 250mg/62.50mg Tablet, it is important to consult your doctor promptly. Additionally, seek immediate medical help if you encounter any signs of an allergic reaction such as rashes, itching, swelling, or shortness of breath after taking this medication. Moreover, if you are pregnant, breastfeeding, or have any existing health conditions requiring medication, it is advisable to consult your doctor before starting Pulmocef CV 250mg/62.50mg Tablet. Furthermore, if you feel excessively drowsy or dizzy after consuming the medicine, refrain from driving and seek medical advice. Remember to complete the prescribed course of treatment even if you start feeling better, as abrupt discontinuation may reduce the medicine's effectiveness. In case of any concerns or persistent side effects, do not hesitate to consult your healthcare provider.
Side effects of Pulmocef CV 250mg/62.50mg Tablet
When taking Pulmocef CV 250mg/62.50mg Tablet, you may experience various side effects, although most of them do not typically need medical attention. These side effects often diminish as your body becomes accustomed to the medication. If any side effects persist or if you are concerned about them, it is important to consult your doctor. Some common side effects of Pulmocef CV 250mg/62.50mg Tablet include nausea, vomiting, and diarrhea. Additionally, the medicine may lead to an increase in liver enzymes, which can be monitored by your healthcare provider. In rare cases, individuals may also experience allergic reactions to this medication. If you observe any of these side effects or have any concerns, seek medical guidance promptly.
Safety advice

liver
Limited information is available on the use of Pulmocef CV 250mg/62.50mg Tablet in patients with liver disease. It is strongly advised to consult your doctor regarding the safety of using this medication if you have liver issues. Your doctor will be able to provide you with proper guidance and assess the risks and benefits of taking Pulmocef CV 250mg/62.50mg Tablet in relation to your liver health.

kidney
Limited information is available regarding the use of Pulmocef CV 250mg/62.50mg Tablet in patients with kidney disease. Please consult your doctor for proper guidance.

alcohol
When taking Pulmocef CV 250mg/62.50mg Tablet, it is safe to consume alcohol as it does not result in any harmful side effects.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Pulmocef CV 250mg/62.50mg Tablet.

pregnancy
Pulmocef CV 250mg/62.50mg Tablet is generally safe during pregnancy. Animal studies show minimal harm to the baby, but limited human studies are available.

breastfeeding
Pulmocef CV 250mg/62.50mg Tablet is considered safe for breastfeeding mothers. Studies show the drug does not pass into the breastmilk in harmful amounts.
Consumption warning before consuming Pulmocef CV 250mg/62.50mg Tablet
Before consuming Pulmocef CV 250mg/62.50mg Tablet, it is essential to follow certain precautions. This medication is prescribed for bacterial infections and should be taken as directed by your healthcare provider. It can be consumed with or without food at a consistent time for optimal results. Avoid exceeding the prescribed dosage to prevent any adverse effects on your health. In case of a missed dose, take it promptly. Completing the full course of treatment is crucial, even if symptoms improve, as stopping abruptly can reduce its effectiveness.
Common side effects may include nausea, vomiting, and diarrhea. If these worsen, contact your doctor. Seek immediate medical assistance if you notice any signs of an allergic reaction. Inform your doctor about any other medications you are taking, and pregnant or breastfeeding women should seek advice before using. Alcohol consumption may lead to excessive drowsiness, so caution is advised. While this medicine typically does not impact driving ability, refrain from driving if it induces drowsiness or dizziness. Adequate rest, a balanced diet, and hydration are recommended for a speedy recovery. Your doctor may request tests to monitor the medication's impact.
What if you forgot to take Pulmocef CV 250mg/62.50mg Tablet?
If you forget to take a dose of Pulmocef CV 250mg/62.50mg Tablet, try to take it as soon as you remember. But if it's close to the time for your next dose, it's better to skip the missed one and continue with your usual dosing schedule. Remember not to take a double dose to make up for the missed one.
Related lab tests
For individuals taking Pulmocef CV 250mg/62.50mg Tablet, related lab tests may include a Complete Blood Count (CBC) and a Peripheral Smear Examination. These tests can help in monitoring the effects of the medication on the blood cell count and structure. A Complete Blood Count provides detailed information about the different types of blood cells present, such as white blood cells, red blood cells, and platelets. It helps in detecting any abnormalities or changes in the blood that may be associated with the medication. A Peripheral Smear Examination involves looking at a blood sample under a microscope to assess the size, shape, and overall appearance of blood cells. This test can help in diagnosing certain blood disorders or infections. Regularly monitoring these lab tests can be important to ensure the proper function and health of the blood cells while using Pulmocef CV 250mg/62.50mg Tablet.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹459
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025